HOME >> BIOLOGY >> NEWS
Plant hemoglobins: Oxygen handlers critical for nitrogen fixation

Hemoglobins, key components of our blood, are ancient proteins with well-known roles in oxygen transport and respiration in animals. Hemoglobins are also present in plants and bacteria, but until now the physiological role of plant hemoglobins has been unclear. A group of researchers reveal this week that one such mysterious plant hemoglobin serves to assist in the fixation of nitrogen in the root nodules of legumes through a process that is conceptually not unlike that undertaken by mammalian hemoglobins in facilitating oxygen transport and exchange in the blood.

The most conspicuous plant hemoglobins are the symbiotic hemoglobins of legumes; these hemoglobins accumulate in root nodules and give these specialized organs their distinctive red color. Legume root nodules accommodate bacteria, called rhizobia, that reduce atmospheric nitrogen to ammonia, which is subsequently used by the plant for growth and colonization of nitrogen-poor soils. Symbiotic nitrogen fixation is important for sustainable agriculture and contributes millions of tons of reduced nitrogen to crops and pastures each year.

As reported this week, researchers led by Dr. Michael Udvardi at the Max Planck Institute of Molecular Plant Physiology have succeeded in eliminating the production of symbiotic hemoglobins in nodules of the model legume Lotus japonicus, enabling researchers to assess for the first time the role and importance of these proteins in plants. The results of the study indicate that symbiotic hemoglobins are important for oxygen transport and energy metabolism in plant root nodules. Furthermore, these proteins help to maintain free-oxygen concentrations in nodules at levels low enough to avoid damage of oxygen-sensitive nitrogenase, the bacterial enzyme complex responsible for symbiotic nitrogen fixation. Thus, plant hemoglobins fulfill roles analogous to those of animal hemoglobins, as well as novel roles that are apparently unique to symbiotic nitrogen fixation.
'"/>

Contact: Heidi Hardman
hhardman@cell.com
1-617-397-2879
Cell Press
28-Mar-2005


Page: 1 2

Related biology news :

1. Plant diseases and issues that are of importance to Californias economy and agriculture
2. Plants recognize their siblings, biologists discover
3. Plants that produce more vitamin C may result from UCLA-Dartmouth discovery
4. Plants tag insect herbivores with an alarm
5. Plant pathologists fighting global threat to wheat supply
6. Plants with male and bisexual flowers on the same plant are better mothers
7. Plants do not emit methane
8. FSU leads botanical research into 21st century: Deep South Plant Specimen Imaging Project
9. Mother knows best: Plant knowledge key to childhood health in remote Amazon
10. Plants management of nutrient suggests environmental remedies
11. Plant size morphs dramatically as scientists tinker with outer layer

Post Your Comments:
(Date:5/20/2013)... 2013) - A novel vaccine study from ... research that will be unveiled at the American Association ... meeting takes place Monday, May 20 - Wednesday, May ... , "The main goal of a vaccine is ... pathogen that causes the disease", explained Dr. Hemachand Tummala, ...
(Date:5/19/2013)... at the University of California, Davis have engineered a ... for light. They report their findings today at ... Microbiology. , "In this work, we used synthetic biology ... carbon dioxide and light energy for growth) cyanobacterial metabolism ... Jordan McEwen, the lead researcher on the study. ...
(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...
Breaking Biology News(10 mins):Germ-fighting vaccine system makes great strides in delivery 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2
(Date:5/21/2013)... Alpha Source, Inc., a Wisconsin-based ... exhibiting for the 13th consecutive year at the ... 2013 Conference and Expo. The conference brings together ... healthcare technologies. This year’s event will be held ... , The three-day event draws over 1,500 healthcare ...
(Date:5/21/2013)... NC (PRWEB) May 21, 2013 ... financial services company for clinical trials, announced today ... Spend Solutions, LLC. Clinverse’s ClinPay® FLS eClinical ... investigator payment process. SpendMD ™, Aggregate ... complete solution for tracking and reporting transfer of ...
(Date:5/21/2013)... As the R&D sector becomes increasingly ... industry to deliver better products, faster. Collaborations between ... often means turning big ideas into reality, within ... with Sensidose AB and Recipharm, is one example ... market sooner. The partnership resulted in the development ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: